...Analyst tracks Biren Amin has left as biotechnology and healthcare sector analyst at WJB Capital to join...

...see BioCentury, Jan. 24). Elan Corp. plc (NYSE:ELN) Jefferies Corey Davis New Buy 7% $6.92 WJB Capital...
...NYSE:NVS; SIX:NOVN). sanofi-aventis Group (Euronext:SAN; NYSE:SNY) markets Lovenox, a low-molecular weight heparin. Vivus Inc. (NASDAQ:VVUS) WJB Capital...

...Russo Upgrade Market outperform (from neutral) -2% $36.40 Leerink Howard Liang Price target Market outperform WJB Capital...

...Cutler Upgrade Buy (from hold) 152% $34.89 Wedbush Katherine Xu Upgrade Market outperform (from neutral) WJB Capital...

...Windley Price target Hold -25% $11.07 Leerink Steve Yoo Downgrade Market perform (from market outperform) WJB Capital...

..."Staccato Stumble," A13). Alkermes Inc. (NASDAQ:ALKS) Jefferies David Windley Downgrade Hold (from buy) -7% $14.80 WJB Capital...

...16% $15.48 Canaccord Adam Cutler Price target Hold Leerink Howard Liang Price target Market outperform WJB Capital...

...where he was a managing director and head of biotechnology equity research. Biren Amin joined WJB Capital...